Procurement of Cytostatics in the Republic of Srpska
2019
Preuzimanje 🢃
Konferencijski prilog (Objavljena verzija)
Metapodaci
Prikaz svih podataka o dokumentuApstrakt
In 2017, there were 36 543 patients with cancer
in the hospitals in Republic of Srpska (RS). The trend for the growth of diseased patients of
younger age is evident.The costs for cytostatics in 2017 year amounted
to 14,31millions EUR. Procurement of cytostatics at the tertiary level of
healthcare is provided through the Health
Insurance Fund of Republic of Srpska and has
been conducted through public procurement. Very often there are the shortages of cytostatics
in the hospitals. The patients are forced to take over the
procurement of these drugs themselves. Patients are forced to buy drugs in other
countries.
Ključne reči:
cytostatics / Republic of SrpskaIzvor:
79th FIP World Congress of Pharmacy and Pharmaceutical Sciences, 22-26 September, 2019. Abu Dhabi, United Arab Emirates, 2019Izdavač:
- International Pharmaceutical Federation (FIP)
Napomena:
- FIP 2019 Abu Dhabi
- Poster presentation
Institucija/grupa
PharmacyTY - CONF AU - Kopanja, Đurđica AU - Zrilić, Mira AU - Kundaković, Tatjana PY - 2019 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5499 AB - In 2017, there were 36 543 patients with cancer in the hospitals in Republic of Srpska (RS). The trend for the growth of diseased patients of younger age is evident.The costs for cytostatics in 2017 year amounted to 14,31millions EUR. Procurement of cytostatics at the tertiary level of healthcare is provided through the Health Insurance Fund of Republic of Srpska and has been conducted through public procurement. Very often there are the shortages of cytostatics in the hospitals. The patients are forced to take over the procurement of these drugs themselves. Patients are forced to buy drugs in other countries. PB - International Pharmaceutical Federation (FIP) C3 - 79th FIP World Congress of Pharmacy and Pharmaceutical Sciences, 22-26 September, 2019. Abu Dhabi, United Arab Emirates T1 - Procurement of Cytostatics in the Republic of Srpska UR - https://hdl.handle.net/21.15107/rcub_farfar_5499 ER -
@conference{ author = "Kopanja, Đurđica and Zrilić, Mira and Kundaković, Tatjana", year = "2019", abstract = "In 2017, there were 36 543 patients with cancer in the hospitals in Republic of Srpska (RS). The trend for the growth of diseased patients of younger age is evident.The costs for cytostatics in 2017 year amounted to 14,31millions EUR. Procurement of cytostatics at the tertiary level of healthcare is provided through the Health Insurance Fund of Republic of Srpska and has been conducted through public procurement. Very often there are the shortages of cytostatics in the hospitals. The patients are forced to take over the procurement of these drugs themselves. Patients are forced to buy drugs in other countries.", publisher = "International Pharmaceutical Federation (FIP)", journal = "79th FIP World Congress of Pharmacy and Pharmaceutical Sciences, 22-26 September, 2019. Abu Dhabi, United Arab Emirates", title = "Procurement of Cytostatics in the Republic of Srpska", url = "https://hdl.handle.net/21.15107/rcub_farfar_5499" }
Kopanja, Đ., Zrilić, M.,& Kundaković, T.. (2019). Procurement of Cytostatics in the Republic of Srpska. in 79th FIP World Congress of Pharmacy and Pharmaceutical Sciences, 22-26 September, 2019. Abu Dhabi, United Arab Emirates International Pharmaceutical Federation (FIP).. https://hdl.handle.net/21.15107/rcub_farfar_5499
Kopanja Đ, Zrilić M, Kundaković T. Procurement of Cytostatics in the Republic of Srpska. in 79th FIP World Congress of Pharmacy and Pharmaceutical Sciences, 22-26 September, 2019. Abu Dhabi, United Arab Emirates. 2019;. https://hdl.handle.net/21.15107/rcub_farfar_5499 .
Kopanja, Đurđica, Zrilić, Mira, Kundaković, Tatjana, "Procurement of Cytostatics in the Republic of Srpska" in 79th FIP World Congress of Pharmacy and Pharmaceutical Sciences, 22-26 September, 2019. Abu Dhabi, United Arab Emirates (2019), https://hdl.handle.net/21.15107/rcub_farfar_5499 .